← All themes Genomics & Gene Editing

Gene Therapy

Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.

131 stocks

#	Name	Holding	Trade Value	% of Portfolio	Status
1801	Hancock Whitney Gulfport, Mississippi	$0	-$201K	–	Closed
1802	HR Hayden Royal Charlotte, North Carolina	$0	-$217K	–	Closed
1803	Heritage Investors Management Corp Bethesda, Maryland	$0	-$46K	–	Closed
1804	HCMT Highland Capital Management (Tennessee) Memphis, Tennessee	$0	-$975K	–	Closed
1805	HFP Holistic Financial Partners Indianapolis, Indiana	$0	-$371K	–	Closed
1806	HI Human Investing Lake Oswego, Oregon	$0	-$39K	–	Closed
1807	II Ibex Investors Denver, Colorado	$0	-$278K	–	Closed
1808	IAS IMA Advisory Services Denver, Colorado	$0	-$4K	–	Closed
1809	ING Group Amsterdam, Netherlands	$0	-$1.56M	–	Closed
1810	IAM Integre Asset Management New York	$0	-$284K	–	Closed
1811	ISB Iowa State Bank Urbandale, Iowa	$0	-$12K	–	Closed
1812	IM Islet Management New York	$0	-$4.57M	–	Closed
1813	JGGDR JGP Global Gestao de Recursos Rio De Janeiro, Brazil	$0	-$365K	–	Closed
1814	KCPG Kavar Capital Partners Group Leawood, Kansas	$0	-$5K	–	Closed
1815	LA Legacy Advisors Plymouth Meeting, Pennsylvania	$0	-$78K	–	Closed
1816	MC Machina Capital Paris, France	$0	-$72K	–	Closed
1817	MF Manchester Financial Westlake Village, California	$0	-$49K	–	Closed
1818	MCM Maple Capital Management Montpelier, Vermont	$0	-$205K	–	Closed
1819	Menora Mivtachim Holdings Ramat Gan, Israel	$0	-$18M	–	Closed
1820	Meridian Wealth Management Lexington, Kentucky	$0	-$99.2K	–	Closed
1821	MC Miramar Capital Northbrook, Illinois	$0	-$229K	–	Closed
1822	MS Mizuho Securities Tokyo, Japan	$0	-$64K	–	Closed
1823	MA MYDA Advisors Woodmere, New York	$0	-$1.53M	–	Closed
1824	NICM Neo Ivy Capital Management New York	$0	-$1.82M	–	Closed
1825	NEPWA New England Private Wealth Advisors Wellesley, Massachusetts	$0	-$379K	–	Closed